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R E P L Y
We would like to thank Dr. Santulli et al. (1) for their interest in
our recently published paper. In their letter, they point out an
important issue regarding patients undergoing cardiac resynchroni-
zation therapy (CRT), namely, the consequences of CRT on left
atrial (LA) function and remodeling. Despite extensive evidence of
the benefits of CRT on ventricular function, the impact of CRT on
atrial function and remodeling has not been thoroughly evaluated.
Previous studies demonstrated that in patients in whom left
ventricular remodeling occurs, favorable changes in LA volumes
and LA function can also be seen (2,3). These changes are expected
to translate into reduced incidence of atrial arrhythmias, secondary
to positive LA remodeling (2,4). That may be important as
occurrence of atrial fibrillation is associated with worse prognosis in
heart failure patients (5).
As recently demonstrated through analysis of a large multicenter
trial (2), and single-center experience (4), CRT-defibrillator ther-
apy was associated with pronounced reverse remodeling of the LA.
This beneficial effect on LA volumes was followed by substantial
reduction in the risk of atrial fibrillation. Importantly, patients whoid not report atrial arrhythmias after device implantation showed
significantly lower incidence of heart failure and death (2).
Our study (1) was mainly focused on evaluating the impact of
xtensive left ventricle remodeling on subsequent response to CRT,
n terms of left ventricular ejection fraction improvement and
ccurrence of cardiac events at follow-up. Hence, the study was not
eared to specifically evaluate changes in LA remodeling. However,
A volume index was enlarged at baseline (44  20 ml/m2), and it
was significantly reduced at follow-up after CRT (39.6  15
l/m2, p  0.01), as was mitral regurgitation severity (see Carluc-
cio et al. [1]). Whether these beneficial changes on LA remodeling,
and their relationship with diastolic left ventricle parameters, are
also associated with lower risk of developing atrial arrhythmias
remains the object of future studies.
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